These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6177249)

  • 1. The enzymatic mechanism of the otospongiotic disease and NaF action on the enzymatic balance.
    Causse JR; Uriel J; Berges J; Shambaugh GE; Bretlau P; Causse JB
    Am J Otol; 1982 Apr; 3(4):297-314. PubMed ID: 6177249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enzymatic mechanism of otosclerosis. Action of NaF].
    Causse JR; Uriel J; Berges J; Bretlau P; Causse JB
    Ann Otolaryngol Chir Cervicofac; 1981; 98(6):269-97. PubMed ID: 6174065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective changes in trypsin, alpha 1-antitrypsin, and alpha 2-macroglobulin values as a result of sodium fluoride treatment in patients with otosclerosis.
    Causse JR; Uriel J; Berges J; Bretlau P; Shambaugh GE; Causse JB
    Am J Otol; 1985 Jan; 6(1):38-42. PubMed ID: 2579564
    [No Abstract]   [Full Text] [Related]  

  • 4. Otospongiosis as a genetic disease. Early detection, medical management, and prevention.
    Causse JR; Causse JB
    Am J Otol; 1984 Jan; 5(3):211-23. PubMed ID: 6372501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymology of otospongiosis and NaF therapy.
    Causse JR; Shambaugh GE; Causse B; Bretlau P
    Am J Otol; 1980 Apr; 1(4):206-14. PubMed ID: 6969991
    [No Abstract]   [Full Text] [Related]  

  • 6. [A biochemical and cytological explanation of cochlear otospongiosis].
    Chevance LG; Causse J; Berges J; Manach Y; Adrian M
    Ann Otolaryngol Chir Cervicofac; 1976; 93(4-5):275-87. PubMed ID: 1085115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of otosclerosis by impedance-audiometry screening.
    Causse JR; Causse JB
    Scand Audiol Suppl; 1983; 17():47-54. PubMed ID: 6577559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies on fluoride in otospongiosis.
    Causse JR; Causse JB
    Am J Otol; 1985 Jan; 6(1):51-5. PubMed ID: 2579565
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification with NaF in disequilibrium of otospongiotic origin.
    Bretlau P; Causse JB; Causse J
    Adv Otorhinolaryngol; 1982; 28():73-9. PubMed ID: 7113821
    [No Abstract]   [Full Text] [Related]  

  • 10. [A biochemical and cytological explanation of cochlear otospongiosis].
    Chevance LG
    Acta Otolaryngol; 1976; 81(3-4):200-3. PubMed ID: 1083621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progressive sensorineural hearing loss in cochlear otosclerosis].
    Sellari-Franceschini S; Ravecca F; De Vito A; Berrettini S
    Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):59-65. PubMed ID: 10205935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Otospongiosis has a genetic disease its early detection its medical management (author's transl)].
    Causse JR; Causse JB
    Ann Otolaryngol Chir Cervicofac; 1980; 97(4-5):325-51. PubMed ID: 7406415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Otospongiosis: morphologic and microchemical investigation after NaF-treatment.
    Bretlau P; Hansen HJ; Causse J; Causse JB
    Otolaryngol Head Neck Surg; 1981; 89(4):646-50. PubMed ID: 6793977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Computer technology in otospongiosis. 2. Statistics on 15 years of stapedectomy].
    Causse J; Bel J; Michaux P; Cezard R; Tapon J; Canut Y
    Ann Otolaryngol Chir Cervicofac; 1976 Sep; 93(9):543-76. PubMed ID: 1023793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium fluoride: effectiveness of treatment for cochlear otosclerosis.
    Forquer BD; Linthicum FH; Bennett C
    Am J Otol; 1986 Mar; 7(2):121-5. PubMed ID: 3963156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How and when to prescribe sodium fluoride.
    Shambaugh GE
    Am J Otol; 1989 Mar; 10(2):146-7. PubMed ID: 2735387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1-antitrypsin activity of perilymph. Occurrence during progression of otospongiosis.
    Chevance LG; Causse JR; Bergès J
    Arch Otolaryngol; 1976 Jun; 102(6):363-4. PubMed ID: 1084149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Audiometric analyses confirm a cochlear component, disproportional to age, in stapedial otosclerosis.
    Topsakal V; Fransen E; Schmerber S; Declau F; Yung M; Gordts F; Van Camp G; Van de Heyning P
    Otol Neurotol; 2006 Sep; 27(6):781-7. PubMed ID: 16885785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on pathology and therapy of otospongiosis.
    Petrovic AG; Stutzmann JJ; Shambaugh GE
    Am J Otol; 1985 Jan; 6(1):43-50. PubMed ID: 2983562
    [No Abstract]   [Full Text] [Related]  

  • 20. Ten years experience with fluoride in otosclerotic (otospongiotic) patients.
    Shambaugh GE; Causse J
    Ann Otol Rhinol Laryngol; 1974; 83(5):635-42. PubMed ID: 4416065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.